cladribine has been researched along with Castleman Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alves, AC; Bordin, JO; Colleoni, GW; de Oliveira, JS; de Souza, VA; Duarte, LC; Kerbauy, FR; Lobão, M; Yunis, MP | 1 |
| Bordeleau, L; Bredeson, C; Markman, S | 1 |
2 other study(ies) available for cladribine and Castleman Disease
| Article | Year |
|---|---|
2-Chloro-deoxyadenosine induces durable complete remission in Castleman's disease but may accelerate its transformation to non-Hodgkin's lymphoma.
Topics: Adult; Castleman Disease; Cladribine; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Remission Induction; Treatment Outcome | 2003 |
2-Chloro-deoxyadenosine therapy for giant lymph node hyperplasia.
Topics: Adult; Antineoplastic Agents; Castleman Disease; Cladribine; Female; Humans; Male; Middle Aged | 1995 |